Citizens’ preferences for brand name drugs for treating acute and chronic conditions
Author
Abstract
Suggested Citation
DOI: 10.2165/11533030-000000000-00000
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Bernie O'Brien & Jose Luis Viramontes, 1994. "Willingness to Pay," Medical Decision Making, , vol. 14(3), pages 289-297, August.
- Wagner, Todd H. & Hu, Teh-wei & Duenas, Grace V. & Kaplan, Celia P. & Nguyen, Bang H. & Pasick, Rena J., 2001. "Does willingness to pay vary by race/ethnicity? An analysis using mammography among low-income women," Health Policy, Elsevier, vol. 58(3), pages 275-288, December.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Costa-Font, Joan & Rudisill, Caroline & Tan, Stefanie, 2014. "Brand loyalty, patients and limited generic medicines uptake," Health Policy, Elsevier, vol. 116(2), pages 224-233.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Rashmita Basu, 2013. "Willingness-to-pay to prevent Alzheimer’s disease: a contingent valuation approach," International Journal of Health Economics and Management, Springer, vol. 13(3), pages 233-245, December.
- Mark Sculpher & Amiram Gafni, 2001. "Recognizing diversity in public preferences: The use of preference sub‐groups in cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 10(4), pages 317-324, June.
- Kevin Haninger & James K. Hammitt, 2011.
"Diminishing Willingness to Pay per Quality‐Adjusted Life Year: Valuing Acute Foodborne Illness,"
Risk Analysis, John Wiley & Sons, vol. 31(9), pages 1363-1380, September.
- Hammitt, James & Haninger, Kevin, 2010. "Diminishing Willingness to Pay per Quality-Adjusted Life Year: Valuing Acute Foodborne Illness," LERNA Working Papers 11.01.335, LERNA, University of Toulouse.
- Hammitt, James K. & Haninger, Kevin, 2010. "Diminishing Willingness to Pay per Quality-Adjusted Life Year: Valuing Acute Foodborne Illness," TSE Working Papers 10-268, Toulouse School of Economics (TSE).
- Huajie Jin & Paul Tappenden & Stewart Robinson & Evanthia Achilla & David Aceituno & Sarah Byford, 2020. "Systematic review of the methods of health economic models assessing antipsychotic medication for schizophrenia," PLOS ONE, Public Library of Science, vol. 15(7), pages 1-18, July.
- Alan Shiell & Janelle Seymour & Penelope Hawe & Sue Cameron, 2000. "Are preferences over health states complete?," Health Economics, John Wiley & Sons, Ltd., vol. 9(1), pages 47-55, January.
- Klose, Thomas, 1999. "The contingent valuation method in health care," Health Policy, Elsevier, vol. 47(2), pages 97-123, May.
- Bernt Kartman & Nils‐Olov Stålhammar & Magnus Johannesson, 1996. "Valuation of health changes with the contingent valuation method: A test of scope and question order effects," Health Economics, John Wiley & Sons, Ltd., vol. 5(6), pages 531-541, November.
- Richard D. Smith, 2007. "The relationship between reliability and size of willingness‐to‐pay values: a qualitative insight," Health Economics, John Wiley & Sons, Ltd., vol. 16(2), pages 211-216, February.
- James K. Hammitt, 2002. "QALYs Versus WTP," Risk Analysis, John Wiley & Sons, vol. 22(5), pages 985-1001, October.
- Tang, Chao-Hsiun & Liu, Jin-Tan & Chang, Ching-Wen & Chang, Wen-Ying, 2007. "Willingness to pay for drug abuse treatment: Results from a contingent valuation study in Taiwan," Health Policy, Elsevier, vol. 82(2), pages 251-262, July.
- M. R. Bhatia, 2005. "From evidence to calibration for starting point bias: willingness to pay for treated mosquito nets in Gujarat, India," Applied Economics, Taylor & Francis Journals, vol. 37(1), pages 1-7.
- Yang, Lin, 2017. "Measuring individual well-being: A multidimensional index integrating subjective well-being and preferences," LSE Research Online Documents on Economics 103495, London School of Economics and Political Science, LSE Library.
- Dorte Gyrd‐Hansen & Trine Kjær, 2012. "Disentangling WTP per QALY data: different analytical approaches, different answers," Health Economics, John Wiley & Sons, Ltd., vol. 21(3), pages 222-237, March.
- Shiell, Alan & Sperber, Daniel & Porat, Carly, 2009. "Do taboo trade-offs explain the difficulty in valuing health and social interventions?," Journal of Behavioral and Experimental Economics (formerly The Journal of Socio-Economics), Elsevier, vol. 38(6), pages 935-939, December.
- Pedersen, Line Bjørnskov & Gyrd-Hansen, Dorte & Kjær, Trine, 2011. "The influence of information and private versus public provision on preferences for screening for prostate cancer: A willingness-to-pay study," Health Policy, Elsevier, vol. 101(3), pages 277-289, August.
- Phillips, Kathryn A. & Homan, Rick K. & Luft, Harold S. & Hiatt, Patricia H. & Olson, Kent R. & Kearney, Thomas E. & Heard, Stuart E., 1997. "Willingness to pay for poison control centers," Journal of Health Economics, Elsevier, vol. 16(3), pages 343-357, June.
- Paul McNamee & Laura Ternent & Adjima Gbangou & David Newlands, 2010. "A game of two halves? Incentive incompatibility, starting point bias and the bidding game contingent valuation method," Health Economics, John Wiley & Sons, Ltd., vol. 19(1), pages 75-87, January.
- David M. Cutler & Elizabeth Richardson, 1999.
"Your Money and Your Life: The Value of Health and What Affects It,"
NBER Chapters, in: Frontiers in Health Policy Research, volume 2, pages 99-132,
National Bureau of Economic Research, Inc.
- David M. Cutler & Elizabeth Richardson, 1999. "Your Money and Your Life: The Value of Health and What Affects It," NBER Working Papers 6895, National Bureau of Economic Research, Inc.
- Cam Donaldson & Phil Shackley & Mona Abdalla & Zosia Miedzybrodzka, 1995. "Willingness to pay for antenatal carrier screening for cystic fibrosis," Health Economics, John Wiley & Sons, Ltd., vol. 4(6), pages 439-452, November.
- Cam Donaldson & Stephen Birch & Amiram Gafni, 2002. "The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes," Health Economics, John Wiley & Sons, Ltd., vol. 11(1), pages 55-70, January.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:aphecp:v:9:y:2011:i:2:p:81-87. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.